Eldelumab (Anti-CXCL10 / IP-10)

Synonyms: BMS-936557; MDX-1100

Eldelumab (Anti-CXCL10 / IP-10) is a humanised monoclonal antibody (IgG1 type) targeting CXCL10. Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease. MW: 145.5 KD.

Eldelumab (Anti-CXCL10 / IP-10)

Purity & Quality Control

Batch: A252501 Purity: 99% Protein concentration: 6.43mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CXCR Inhibitors

Biological Activity

Description Eldelumab (Anti-CXCL10 / IP-10) is a humanised monoclonal antibody (IgG1 type) targeting CXCL10. Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease. MW: 145.5 KD.

Product Details

CAS No. 946414-98-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Eldelumab (Anti-CXCL10 / IP-10) | Eldelumab (Anti-CXCL10 / IP-10) supplier | purchase Eldelumab (Anti-CXCL10 / IP-10) | Eldelumab (Anti-CXCL10 / IP-10) cost | Eldelumab (Anti-CXCL10 / IP-10) manufacturer | order Eldelumab (Anti-CXCL10 / IP-10) | Eldelumab (Anti-CXCL10 / IP-10) distributor